Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001401914-20-000118
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$7.58M | -$3.39M | -$2.57M | -$1.63M |
| EPS Diluted | -$0.24 | -$0.20 | -$0.23 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
